Ptc Therapeutics reported $1.21B in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 36522M 332M
Biocryst Pharmaceuticals BCRX:US $ 622.18M 17.72M
Biogen BIIB:US $ 7277.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Cytokinetics CYTK:US $ 199.42M 1.44M
Daiichi Sankyo 4568:JP Y 163367M 94M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Esperion Therapeutics ESPR:US $ 259.08M 402K
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
IONIS PHARMACEUT IONS:US $ 1253.13M 1M
Ironwood Pharmaceuticals IRWD:US $ 395.45M 120.18M
Karyopharm Therapeutics KPTI:US $ 302.69M 202K
Novartis NOVN:VX SF 31031M 244M
Ptc Therapeutics PTCT:US $ 1207.54M 10.46M
Puma Biotechnology PBYI:US $ 97.68M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 34.19M 0.01M